日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Highly pathogenic avian H5N1 influenza A virus replication in ex vivo cultures of bovine mammary gland and teat tissues

高致病性禽流感H5N1 A病毒在牛乳腺和乳头组织离体培养物中的复制

Imai, Masaki; Ueki, Hiroshi; Ito, Mutsumi; Iwatsuki-Horimoto, Kiyoko; Kiso, Maki; Biswas, Asim; Trifkovic, Sanja; Cook, Nigel; Halfmann, Peter J; Neumann, Gabriele; Eisfeld, Amie J; Kawaoka, Yoshihiro

Transmission of bovine H5N1 virus in a hamster model

牛H5N1病毒在仓鼠模型中的传播

Iwatsuki-Horimoto, Kiyoko; Uraki, Ryuta; Ito, Mutsumi; Wang, Tong; Guan, Lizheng; Halfmann, Peter; Eisfeld, Amie; Neumann, Gabriele; Yamayoshi, Seiya; Kawaoka, Yoshihiro

An XBB.1.5-based inactivated SARS-CoV-2 vaccine partially protects against XBB.1.5 and JN.1 strains in hamsters.

基于 XBB.1.5 的灭活 SARS-CoV-2 疫苗可对仓鼠中的 XBB.1.5 和 JN.1 毒株提供部分保护

Uraki Ryuta, Ito Mutsumi, Kiso Maki, Iwatsuki-Horimoto Kiyoko, Endo Masafumi, Yamayoshi Seiya, Kawaoka Yoshihiro

A human isolate of bovine H5N1 is transmissible and lethal in animal models.

从人体内分离出的牛源H5N1病毒具有传染性,并且在动物模型中具有致死性。

Gu Chunyang, Maemura Tadashi, Guan Lizheng, Eisfeld Amie J, Biswas Asim, Kiso Maki, Uraki Ryuta, Ito Mutsumi, Trifkovic Sanja, Wang Tong, Babujee Lavanya, Presler Robert Jr, Dahn Randall, Suzuki Yasuo, Halfmann Peter J, Yamayoshi Seiya, Neumann Gabriele, Kawaoka Yoshihiro

Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection case.

在 Delta 突破性感染病例中诱导产生对 SARS-CoV-2(包括 Omicron 亚型)具有广泛中和活性的 IGHV3-53 公共抗体

Kuwata Takeo, Kaku Yu, Biswas Shashwata, Matsumoto Kaho, Shimizu Mikiko, Kawanami Yoko, Uraki Ryuta, Okazaki Kyo, Minami Rumi, Nagasaki Yoji, Nagashima Mami, Yoshida Isao, Sadamasu Kenji, Yoshimura Kazuhisa, Ito Mutsumi, Kiso Maki, Yamayoshi Seiya, Imai Masaki, Ikeda Terumasa, Sato Kei, Toyoda Mako, Ueno Takamasa, Inoue Takako, Tanaka Yasuhito, Kimura Kanako Tarakado, Hashiguchi Takao, Sugita Yukihiko, Noda Takeshi, Morioka Hiroshi, Kawaoka Yoshihiro, Matsushita Shuzo

Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters

仓鼠体内 Omicron BA.4.6、XBB 和 BQ.1.1 亚变体的特征分析

Halfmann, Peter J; Iwatsuki-Horimoto, Kiyoko; Kuroda, Makoto; Hirata, Yuichiro; Yamayoshi, Seiya; Iida, Shun; Uraki, Ryuta; Ito, Mutsumi; Ueki, Hiroshi; Furusawa, Yuri; Sakai-Tagawa, Yuko; Kiso, Maki; Armbrust, Tammy; Spyra, Sam; Maeda, Ken; Wang, Zhongde; Imai, Masaki; Suzuki, Tadaki; Kawaoka, Yoshihiro

Clinical Efficacy of Imdevimab/Casirivimab for Persistent Omicron SARS-CoV-2 Infection in Patients with Hematological Malignancies

Imdevimab/Casirivimab治疗血液系统恶性肿瘤患者持续性Omicron SARS-CoV-2感染的临床疗效

Hagihara, Masao; Hayashi, Hiroyoshi; Nakashima, Shiori; Imai, Yui; Nakano, Hirofumi; Uchida, Tomoyuki; Inoue, Morihiro; Sakai-Tagawa, Yuko; Ito, Mutsumi; Yamayoshi, Seiya; Iwatsuki-Horimoto, Kiyoko; Suzuki, Yutaka; Kawaoka, Yoshihiro

Sensitivity of rodents to SARS-CoV-2: Gerbils are susceptible to SARS-CoV-2, but guinea pigs are not.

啮齿动物对 SARS-CoV-2 的敏感性:沙鼠易感染 SARS-CoV-2,但豚鼠不易感染

Iwatsuki-Horimoto Kiyoko, Kiso Maki, Ito Mutsumi, Yamayoshi Seiya, Kawaoka Yoshihiro

Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB

抗病毒药物对 Omicron 亚型 BQ.1.1 和 XBB 的疗效

Imai, Masaki; Ito, Mutsumi; Kiso, Maki; Yamayoshi, Seiya; Uraki, Ryuta; Fukushi, Shuetsu; Watanabe, Shinji; Suzuki, Tadaki; Maeda, Ken; Sakai-Tagawa, Yuko; Iwatsuki-Horimoto, Kiyoko; Halfmann, Peter J; Kawaoka, Yoshihiro

Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1

抗病毒药物和二价mRNA疫苗对SARS-CoV-2分离株CH.1.1的疗效

Uraki, Ryuta; Ito, Mutsumi; Kiso, Maki; Yamayoshi, Seiya; Iwatsuki-Horimoto, Kiyoko; Sakai-Tagawa, Yuko; Furusawa, Yuri; Imai, Masaki; Koga, Michiko; Yamamoto, Shinya; Adachi, Eisuke; Saito, Makoto; Tsutsumi, Takeya; Otani, Amato; Kashima, Yukie; Kikuchi, Tetsuhiro; Yotsuyanagi, Hiroshi; Suzuki, Yutaka; Kawaoka, Yoshihiro